Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

MMM

3M Reports Slight Sales Increase in Q4 2024

3M has reported its fourth-quarter and full-year 2024 results, showing a slight increase in sales for the fourth quarter. The Q4 sales totaled $6.0 billion, up 0.1% year-on-year, with adjusted sales of $5.8 billion, reflecting organic growth of 2.1% year-on-year.

The GAAP EPS from continuing operations for Q4 was $1.33, marking a 17% increase year-on-year. However, the adjusted EPS from continuing operations for the same period was $1.68, a 2% decrease compared to the previous year.

For the full year 2024, 3M reported sales of $24.6 billion, representing a marginal decline of 0.1% year-on-year. However, adjusted sales for the same period amounted to $23.6 billion, indicating a 1.3% increase year-on-year, with organic growth of 1.2% year-on-year.

In terms of earnings per share, the full-year GAAP EPS from continuing operations was $7.26, while the adjusted EPS from continuing operations stood at $7.30, showing a significant 21% increase compared to the previous year.

Additionally, 3M reported a full-year operating cash flow of $1.8 billion and adjusted free cash flow of $4.9 billion. The company also returned $3.8 billion to shareholders through dividends and share repurchases during the year.

Looking ahead, 3M has provided its full-year 2025 financial guidance, expecting adjusted total sales growth in the range of 0.5 to 1.5%, with adjusted organic sales growth of 2 to 3%. The company anticipates adjusted EPS in the range of $7.60 to $7.90 and adjusted operating cash flow of $5.2 to $5.3 billion for the year.

Today the company's shares have moved 4.4% to a price of $147.29. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS